Cytokinetics Inc
CYTK·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$62.72
Today
-0.3%
YTD
-1.4%
About
Cytokinetics is a biopharmaceutical company with headquarters in South San Francisco, California. Operating within the US, the company develops and commercialises muscle activators and inhibitors to help treat debilitating diseases. Founded in 1998, Cytokinetics is listed on the NASDAQ GS with the CYTK ticker. Make this stock an addition to your eToro watchlist to keep up to date on the CYTK share price.
Price chart
Closing price history for CYTK (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-8.68
P/S (TTM)122.39
P/B (TTM)-50.15
Market cap$8.72B
Cap tierMid-cap
Industry avg P/E-7.40
Profitability
Gross margin69.42%
EBIT margin-1046.12%
Net margin-694.39%
ROE-572.15%
ROA-56.76%
Earnings & Revenue
Revenue (TTM)$67.67M
Revenue growth (1Y)-21.1%
EPS (TTM)-$7.22
Free cash flow$-580.72M
Total debt$1.27B
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.90
Employees673
Next earnings4 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.